{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:50:54Z","timestamp":1783774254415,"version":"3.55.0"},"reference-count":33,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2016,1]]},"abstract":"\nOBJECT<\/jats:title>\nDelayed ischemic neurological deficits (DINDs) and cerebral vasospasm (CVS) are responsible fora poor outcome in patients with aneurysmal subarachnoid hemorrhage (SAH), most likely because of a decreased availability of nitric oxide (NO) in the cerebral microcirculation. In this study, the authors examined the effects of treatment with the NO donor molsidomine with regard to decreasing the incidence of spasm-related delayed brain infarctions and improving clinical outcome in patients with SAH.<\/jats:p><\/jats:sec>\n\nMETHODS<\/jats:title>\nSeventy-four patients with spontaneous aneurysmal SAH were included in this post hoc analysis. Twenty-nine patients with SAH and proven CVS received molsidomine in addition to oral or intravenous nimodipine. Control groups consisted of 25 SAH patients with proven vasospasm and 20 SAH patients without. These patients received nimodipine therapy alone. Cranial computed tomography (CCT) before and after treatment was analyzed for CVS-related infarcts. A modified National Institutes of Health Stroke Scale (mNIHSS) and the modified Rankin Scale (mRS) were used to assess outcomes at a 3-month clinical follow-up.<\/jats:p><\/jats:sec>\n\nRESULTS<\/jats:title>\nFour of the 29 (13.8%) patients receiving molsidomine plus nimodipine and 22 of the 45 (48%) patients receiving nimodipine therapy alone developed vasospasm-associated brain infarcts (p < 0.01). Follow-up revealed a median mNIHSS score of 3.0 and a median mRS score of 2.5 in the molsidomine group compared with scores of 11.5 and 5.0, respectively, in the nimodipine group with CVS (p < 0.001). One patient in the molsidomine treatment group died, and 12 patients in the standard care group died (p < 0.01).<\/jats:p><\/jats:sec>\n\nCONCLUSIONS<\/jats:title>\nIn this post hoc analysis, patients with CVS who were treated with intravenous molsidomine had a significant improvement in clinical outcome and less cerebral infarction. Molsidomine offers a promising therapeutic option in patients with severe SAH and CVS and should be assessed in a prospective study.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2014.12.jns13846","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T14:04:29Z","timestamp":1436537069000},"page":"51-58","source":"Crossref","is-referenced-by-count":24,"title":["Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study"],"prefix":"10.3171","volume":"124","author":[{"given":"Angelika","family":"Ehlert","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Asklepios Hospital St. Georg, Hamburg;\u00a0"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Departments of An\u00e4sthesiology, Intensive Care and Pain Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"W\u00f6lfer","sequence":"additional","affiliation":[{"name":"Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Manthei","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Asklepios Hospital St. Georg, Hamburg;\u00a0"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Jacobs","sequence":"additional","affiliation":[{"name":"European Institute of Molecular Imaging, M\u00fcnster;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Br\u00fcning","sequence":"additional","affiliation":[{"name":"Department of Radiology, Asklepios Hospital Barmbek, Hamburg;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Heindel","sequence":"additional","affiliation":[{"name":"Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Bernd","family":"Ringelstein","sequence":"additional","affiliation":[{"name":"Neurology, University Hospital M\u00fcnster;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Stummer","sequence":"additional","affiliation":[{"name":"Neurosurgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard M.","family":"Pluta","sequence":"additional","affiliation":[{"name":"Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Hesselmann","sequence":"additional","affiliation":[{"name":"Radiology, and"},{"name":"Asklepios Hospital Hamburg North, Hamburg, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns13846","series-title":"Stroke","first-page":"e519","article-title":"Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage","volume":"41","author":"Al-Khindi","year":"2010"},{"key":"b2-jns13846","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1056\/NEJM198303173081103","article-title":"Cerebral arterial spasm\u2014a controlled trial of nimodipine in patients with subarachnoid hemorrhage","volume":"308","author":"Allen","year":"1983"},{"key":"b3-jns13846","series-title":"Adv Second Messenger Phosphoprotein Res","first-page":"434","article-title":"Generation and transmission of vasoactive and antiaggregatory signals by the endothelium","volume":"24","author":"Bassenge","year":"1990"},{"key":"b4-jns13846","series-title":"Dtsch Med Wochenschr","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1055\/s-2005-923325","article-title":"Oxidative stress and cardiovascular diseases","volume":"130","author":"Bassenge","year":"2005"},{"key":"b5-jns13846","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1161\/01.STR.29.12.2575","article-title":"Functional changes in human pial arteries (300 to 900 micrometer ID) within 48 hours of aneurysmal subarachnoid hemorrhage","volume":"29","author":"Bevan","year":"1998"},{"key":"b6-jns13846","series-title":"Basic Res Cardiol","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/BF01907912","article-title":"The role of endothelium in the control of vascular tone","volume":"80","author":"Busse","year":"1985"},{"key":"b7-jns13846","series-title":"Can Anaesth Soc J","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/BF03005505","article-title":"Cerebrospinal fluid cyanide after nitroprusside infusion in man","volume":"28","author":"Casthely","year":"1981"},{"key":"b8-jns13846","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1474-4422(09)70054-7","article-title":"Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use","volume":"8","author":"Dirnagl","year":"2009"},{"key":"b9-jns13846","series-title":"Curr Opin Crit Care","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00075198-200204000-00007","article-title":"Therapeutic approaches to vasospasm in subarachnoid hemorrhage","volume":"8","author":"Dorsch","year":"2002"},{"key":"b10-jns13846","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3171\/jns.2000.93.4.0658","article-title":"Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: a model for delayed ischemic neurological deficits after subarachnoid hemorrhage?","volume":"93","author":"Dreier","year":"2000"},{"key":"b11-jns13846","series-title":"Am J Physiol","first-page":"H1038","article-title":"Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation","volume":"261","author":"Faraci","year":"1991"},{"key":"b12-jns13846","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/01.STR.25.3.692","article-title":"Nitric oxide and the cerebral circulation","volume":"25","author":"Faraci","year":"1994"},{"key":"b13-jns13846","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1161\/STROKEAHA.108.544700","article-title":"Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?","volume":"40","author":"Frontera","year":"2009"},{"key":"b14-jns13846","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1227\/01.NEU.0000338946.42939.C7","article-title":"Resuscitation and critical care of poor-grade subarachnoid hemorrhage","volume":"64","author":"Komotar","year":"2009"},{"key":"b15-jns13846","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1161\/STROKEAHA.109.560243","article-title":"Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis","volume":"40","author":"Kramer","year":"2009"},{"key":"b16-jns13846","series-title":"Neurosurg Rev","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10143-005-0013-5","article-title":"Management of cerebral vasospasm","volume":"29","author":"Loch Macdonald","year":"2006"},{"issue":"3","key":"b17-jns13846","series-title":"Neurosurg Focus","first-page":"E1","article-title":"Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm?","volume":"21","author":"Nolan","year":"2006"},{"key":"b18-jns13846","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1161\/01.STR.31.7.1621","article-title":"Impact of cerebral microcirculatory changes on cerebral blood flow during cerebral vasospasm after aneurysmal subarachnoid hemorrhage","volume":"31","author":"Ohkuma","year":"2000"},{"key":"b19-jns13846","series-title":"Pharmacol Ther","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pharmthera.2004.10.002","article-title":"Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment","volume":"105","author":"Pluta","year":"2005"},{"key":"b20-jns13846","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1001\/jama.293.12.1477","article-title":"Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage","volume":"293","author":"Pluta","year":"2005"},{"key":"b21-jns13846","series-title":"Neurol Res","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1179\/174313209X393564","article-title":"Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought","volume":"31","author":"Pluta","year":"2009"},{"key":"b22-jns13846","series-title":"Neurosurgery","first-page":"884","article-title":"Effects of nitric oxide on reactive oxygen species production and infarction size after brain reperfusion injury","volume":"48","author":"Pluta","year":"2001"},{"key":"b23-jns13846","series-title":"Acta Neurochir Suppl","first-page":"67","article-title":"Nitric oxide and vasospasm","volume":"77","author":"Pluta","year":"2001"},{"key":"b24-jns13846","series-title":"Lancet Neurol","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S1474-4422(11)70017-5","article-title":"Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage","volume":"10","author":"Rinkel","year":"2011"},{"key":"b25-jns13846","series-title":"Clin Pharmacokinet","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2165\/00003088-199630050-00004","article-title":"Clinical pharmacokinetics of molsidomine","volume":"30","author":"Rosenkranz","year":"1996"},{"key":"b26-jns13846","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.9.JNS12492","article-title":"Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial","volume":"118","author":"Senbokuya"},{"key":"b27-jns13846","series-title":"Eur Heart J","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/oxfordjournals.eurheartj.a062268","article-title":"Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study","volume":"8","author":"Serruys","year":"1987"},{"key":"b28-jns13846","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1227\/00006123-198502000-00008","article-title":"Arterial wall changes in early human vasospasm","volume":"16","author":"Smith","year":"1985"},{"key":"b29-jns13846","series-title":"Clin Exp Pharmacol Physiol","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1440-1681.1998.tb02337.x","article-title":"Subarachnoid haemorrhage: what happens to the cerebral arteries?","volume":"25","author":"Sobey","year":"1998"},{"key":"b30-jns13846","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1227\/01.NEU.0000227519.27569.45","article-title":"Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study","volume":"59","author":"Stein","year":"2006"},{"key":"b31-jns13846","series-title":"The Human Brain Circulation: Functional Changes in Disease","first-page":"291","article-title":"Regulation of the circulation of the brain","author":"Ursino","year":"1994"},{"key":"b32-jns13846","series-title":"J Cereb Blood Flow Metab","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/jcbfm.2008.74","article-title":"Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia","volume":"28","author":"Vergouwen","year":"2008"},{"key":"b33-jns13846","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/124\/1\/article-p51.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/124\/1\/article-p51.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/124\/1\/article-p51.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:59:56Z","timestamp":1709978396000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/124\/1\/article-p51.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":33,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2014.12.jns13846","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}